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Abstract 
 
In an effort to probe the reaction mechanism of VanX, the d-ala-d-ala 
dipeptidase required for high-level vancomycin resistance in bacteria, 
stopped-flow kinetic and rapid-freeze quench EPR studies were conducted on 
the Co(II)-substituted enzyme when reacted with d-ala-d-ala. The intensity of 
the Co(II) ligand field band at 550 nm decreased (ε550 = 140 to 18 M-1 cm-1) 
when VanX was reacted with substrate, suggesting that the coordination 
number of the metal increases from 5 to 6 upon substrate binding. The 
stopped-flow trace was fitted to a kinetic mechanism that suggests the 
presence of an intermediate whose breakdown is rate-limiting. Rapid-freeze 
quench EPR studies verified the presence of a reaction intermediate that 
exhibits an unusually low hyperfine constant (33 G), which suggests a 
bidentate coordination of the intermediate to the metal center. The EPR 
studies also identified a distinct enzyme product complex. The results were 
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used to offer a detailed reaction mechanism for VanX that can be used to 
guide future inhibitor design efforts.  
VanX is a Zn(II)-containing metalloenzyme that is required for 
high-level vancomycin resistance in bacteria.1 The intracellular role of 
VanX is to hydrolyze vancomycin-binding d-ala-d-ala dipeptides that 
are used to synthesize the normal bacterial peptidoglycan layer. Many 
vancomycin-resistant bacteria produce d-ala-d-lactate depsipeptides 
that can be inserted into the peptidoglycan layer; however, these 
depsipeptides bind vancomycin 103 weaker than their dipeptide 
counterparts.2,3 Reynolds et al. reported that Enterococcus faecium 
strains containing functional VanX produced vancomycin-susceptible d-
ala-d-ala-containing precursors to vancomycin-resistant d-ala-d-
lactate-containing precursors in a ratio of 1:49.3 The removal of VanX 
activity changed this ratio to 1:1. Clearly, VanX is an excellent target 
for the generation of inhibitors. Toward this effort, several inhibitors 
have been reported for VanX;4-9 however, none of these inhibitors are 
clinically useful. Rational design or redesign of these inhibitors requires 
structural and mechanistic information about the enzyme.10 A crystal 
structure of VanX has been reported, and this structure showed a 
single Zn(II) ion coordinated by two histidines and one aspartate.11 
More recent spectroscopic studies have demonstrated that the Zn(II) 
in VanX is five-coordinate,12 with the other two ligands probably being 
solvent molecules. The crystal structure demonstrated that the active 
site of VanX is contained in a very narrow cavity,11 which explains the 
stringent substrate specificity exhibited by the enzyme.3,5 To date, 
there have been very few mechanistic studies reported on VanX,5,13 
presumably due to the lack of a substrate that can be used in a 
continuous assay. To circumvent this problem, we utilized stopped-
flow optical and rapid-freeze quench EPR studies to probe the metal 
ion in Co(II)-substituted VanX during catalysis.  
 
Zn(II)-containing and Co(II)-substituted VanX−maltose binding 
protein fusions were prepared and characterized as previously 
described.12 The lack of a chromophoric substrate prompted the 
evaluation of alternative methods for investigating the catalytic 
reaction of VanX. No time-resolved changes in tryptophan fluorescence 
were observed upon reaction of Zn−VanX with d-ala-d-ala, but 
changes in the ligand field electronic absorption at 550 nm of 
Co−VanX were observed upon reaction at 2 °C (Figure 1). The time 
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dependence of the absorption was characterized by an initial rapid 
decrease (0−10 ms), followed by first a slow (15−35 ms) and then a 
more rapid reappearance of absorption over the next 120 ms. The 
molar absorptivity of the Co(II) ligand field band at 550 nm was 140 
M-1 cm-1 for the enzyme in both the initial and final states, suggesting 
a coordination number of 5. The molar absorptivity of the enzyme 
after the first 15 ms was 22 M-1 cm-1, indicative of a catalytic 
intermediate with distorted 6-fold coordination of Co(II).  
 
 
Figure 1 Stopped-flow Vis trace (data points) of the reaction of 356 μM Co(II)-
substituted VanX with 356 μM d-ala-d-ala at 2 °C in 20 mM Tris, pH 7.6, containing 
200 mM NaCl. The line was generated by using the Applied Photophysics ProK 
software and the mechanism and rate constants shown in Scheme 1. 
The simplest kinetic mechanism that allows for reversible binding of 
substrate and product, the presence of a reaction intermediate, and 
one substrate/two products is given in Scheme 1.  
 
 
Scheme 1.  Kinetic Mechanism of VanX:  Mechanism Was Used to Fit Stopped-Flow 
Data in Figure 1  
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The stopped-flow trace (Figure 1) was fitted using Applied 
Photophysics ProK software with the following assumptions:  (1) 
binding of substrate and products occurs at the diffusion-controlled 
limit (108 M-1 s-1);14 (2) chemistry steps are essentially irreversible (k-2 
and k-3 set to <1); (3) dissociation constants for both d-ala molecules 
are in the millimolar range; (4) E, EP1, and EP1P2 contain a five-
coordinate metal center, while ES and EI contain a six-coordinate 
center. In analyses with ProK, values for k-1, k2, and k3 were allowed to 
float for χ2 minimizations, while the other constants were fixed. The 
best fit, when using the rate constants in Scheme 1, of the data is 
shown in Figure 1. Fittings with values of k-2 and k-3 ≫ 1 s-1 returned 
unreasonable values for kcat and Km. The errors in k-1, k2, and k3 from 
the fit are less than 5%. The theoretical values for kcat 
(k2k3k4k5/[k4k5(k2 + k-2 + k3) + k-3k5(k2 + k-2) + k2k3(k4 + k5)]) and Km 
(k-1k-2(k-3k5 + k4k5) + k4k5(k2k3 + k-1k3)/[k1(k4k5(k2 + k-2 + k3) + k-
3k5(k2 + k-2) + k2k3(k4 + k5)]) for the mechanism in Scheme 1 are 24 
s-1 and 126 μM, respectively. These theoretical values compare 
favorably with experimentally determined kcat and Km values of 40 s-1 
and 100 μM, respectively, at 2 °C. The data presented in Figure 1 
represent the optimum conditions for the experiment, where (1) each 
of the reaction intermediates can be observed from the resting state 
onward, and (2) the Co(II) d−d bands are sufficiently intense as to be 
discriminating in terms of fit parameters. Numerous other data were 
collected at different concentrations. Due to the kinetics of the initial 
step and the inherently low intensity of Co(II) d−d transitions, the 
data were characterized by either a lack of a contribution of the early 
fast phase of the reaction or a poor signal-to-noise in the data, at high 
and low enzyme concentrations, respectively. Nevertheless, fits to 
these data using the parameters presented in Scheme 1 show that the 
proposed mechanism is consistent with these other data.  
 
To further probe the structure of Co(II) during the reaction, EPR 
spectra were carried out on Co−VanX before, during, and after 
reaction with d-ala-d-ala (Figure 2). The resting state is characterized 
by two EPR signals (Figure 2A,B), each consistent with five-coordinate 
Co(II).12 The EPR signal from a rapid-freeze-quenched sample 
corresponding to 10.5 ms reaction time (Figure 2B,C) was 
characterized by a sharp feature at 1010 G (geff. = 6.8) and broad 
underlying absorption from 1800 to 4000 G. Precise spin Hamiltonian 
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parameters could not be obtained for the broad region, but simulation 
indicated that the spectrum is consistent with an essentially axial S = 
3/2, MS = |±1/2〉 species with greal (x,y) ∼ 2.65, and thus, consistent with 
five- or six-coordinate Co(II).15 Closer examination of the 200−1200 G 
region revealed resolved hyperfine structure, indicative of a very 
highly constrained geometry, just as expected for an intermediate that 
binds similarly as the phosphinate analogue of d-ala-d-ala.11 Even 
more striking evidence for bound intermediate, however, was the 
magnitude of the hyperfine coupling, 33 G (Figure 2G). This compares 
to a typical value of ∼90 G for protein-bound Co(II) and 40−50 G for 
Co(II) with a constituent of a four- or five-atom substrate-derived ring 
system.15 The hyperfine coupling of 33 G from the Co−VanX 
intermediate indicates substantial paramagnetic electron density 
delocalization from the Co(II) ion, likely due to bidentate coordination 
of intermediate to Co(II) with concomitant loss of one of the solvent 
molecules, perhaps as the nucleophile. Interestingly, upon exhaustion 
of substrate, the signal observed from Co−VanX (Figure 2E,F) appears 
to be distinct from the signals observed in the resting enzyme (Figure 
2B).  
 
 
Figure 2 EPR spectra of 1 mM Co−VanX in the resting state (A, B), after 10 ms 
reaction with 5 mM d-ala-d-ala (C, D), and after complete reaction with d-ala-d-ala (E, 
F). The traces in G show the hyperfine region of spectrum C with a simulation overlaid 
indicating AI = 7/2(59Co) = 3.5 × 10-3 cm-1 (33 G). Spectra A, C, E, and G were recorded 
at 9.63 GHz, 11 K, 2 mW; B, D, and F were recorded at 5 K, 200 mW. 
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Thus, the combined data from the present study indicate that (i) 
there is a metal-ion-bound intermediate, EI, of VanX formed during 
the reaction with d-ala-d-ala, (ii) EI is bound in a bidentate fashion to 
the metal ion, and (iii) a distinct product complex exists. With these 
data, a reaction mechanism can be offered (Figure 3). Substrate binds 
to the metal site with the assistance of protonated Arg71 (not shown 
for clarity),13 generating a six-coordinate metal ion. Attack by 
hydroxide, which is generated by Zn(II) and Glu181,13 results in an 
intermediate in which the hitherto sp2-hybridized carbon has become 
tetrahedral and is bidentately bound to six-coordinate Zn(II). The 
source of the proton on the C-terminus of alanine is unknown; 
however, this proton could be donated from Glu181, the nucleophile, 
or another active-site residue. Rate-limiting breakdown of this 
intermediate and loss of the C-terminal d-ala yields an 
enzyme−product complex that is five-coordinate. These findings 
represent the first mechanistic information on VanX and provide useful 
information for the rational design or redesign of clinically useful 
inhibitors of the enzyme.  
 
 
Figure 3 Proposed reaction mechanism of VanX. 
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